HSA | FSA CARDS ARE NOW ACCEPTED

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Mounjaro (tirzepatide) is one of the most-searched GLP-1 medications in the U.S. as of April 2026, and list price, insurance coverage, and out-of-pocket strategies are a frequent question. This article covers the published list price, manufacturer savings programs, insurance considerations, and the compounded-pharmacy alternatives that exist in this space — all as of April 2026 and reported as published, not as guarantees.

Mounjaro list price

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). Out-of-pocket cost varies depending on insurance coverage, the FDA-approved indication for which the prescription is written, manufacturer savings programs, and the pharmacy where the prescription is filled. List price is rarely what most insured patients pay.

Insurance and coverage notes

Coverage for Mounjaro depends on whether the prescription is for an FDA-approved indication and on the specific plan formulary. Many commercial plans cover tirzepatide for type 2 diabetes; coverage for chronic weight management is more variable and often subject to prior authorization or BMI-based criteria. Check directly with your plan as of April 2026.

Mounjaro savings programs and discounts

Eli Lilly publishes a manufacturer savings card program that, for eligible commercially-insured patients, can substantially reduce monthly out-of-pocket cost. Independent pharmacy discount platforms (e.g., GoodRx, SingleCare) also publish coupon prices that vary by pharmacy. Eligibility and savings amounts change over time — verify on the manufacturer website or with your pharmacy at the time of fill.

Compounded alternatives and the FDA shortage context

Between 2022 and 2024, the FDA listed tirzepatide on its drug shortage list, opening a regulatory pathway for licensed 503A compounding pharmacies to compound tirzepatide formulations. The FDA resolved the tirzepatide shortage in 2024, narrowing — but not eliminating — that pathway. Legitimate compounded protocols, when prescribed by a licensed clinician through a state-licensed compounding pharmacy, remain a real option, though pricing and access vary widely.

PlexusDx Weight Management Protocols

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols — including Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. See the relevant product page for current pricing as of April 2026.

Upstream of any GLP-1 protocol decision, the PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights — including variants in FTO, GLP1R, and MC4R that shape baseline GLP-1, appetite-regulation, and energy-balance biology. That genetic context is the test before you invest framing PlexusDx applies to every protocol conversation.

Related reading on PlexusDx: Mounjaro Price, Mounjaro vs Zepbound, What is Mounjaro, Zepbound vs Mounjaro.

Disclaimer: This article is educational. PlexusDx offers tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Learn more about the PlexusDx Tirzepatide protocol or the oral tirzepatide protocol inside the Weight Management Protocols collection. To start upstream with the genetic context, take the Precision Peptide Genetic Test first.

Frequently Asked Questions

How much does Mounjaro cost without insurance?

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing) as of April 2026. Without insurance and without a manufacturer savings card, that list price is what cash-pay patients face at most U.S. pharmacies. Compounded alternatives, manufacturer savings programs, and pharmacy discount cards can substantially reduce out-of-pocket cost.

Is there a coupon or savings card for Mounjaro?

Yes — Eli Lilly publishes a manufacturer savings card for Mounjaro that, for eligible commercially-insured patients, can reduce monthly out-of-pocket cost substantially. Independent pharmacy coupons (GoodRx, SingleCare) also publish discounted prices that vary by pharmacy and change frequently. Verify eligibility at the time of fill.

Why is Mounjaro so expensive?

Mounjaro is a patent-protected branded medication; Eli Lilly sets list price based on R&D cost recovery, market positioning, and expected payer mix. List prices have remained high in part because demand has outpaced manufacturing in 2023–2024. Compounded alternatives and savings programs are the main levers patients use.

Are compounded versions cheaper?

Often yes — compounded tirzepatide prepared by licensed 503A pharmacies has historically been priced significantly below Mounjaro list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA's evolving stance on compounding pathways post-2024 shortage resolution. Discuss with a qualified clinician.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education